# mTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.

> **NCT05198427** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 45 (actual)

## Conditions studied

- Transplantation Organ

## Interventions

- **OTHER:** review of medical patient file

## Key facts

- **NCT ID:** NCT05198427
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-14
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198427, "mTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05198427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*